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Nestin-positive (Nes+) cells are important hematopoi-
esis-supporting constituents in adult bone marrow.
However, how these cells originate during endochon-
dral bone development is unknown. Studies using
mice expressing GFP under the direction of nestin
promoter/enhancer (Nes-GFP) revealeddistinctendo-
thelial and nonendothelial Nes+ cells in the embryonic
perichondrium; the latter were early cells of the osteo-
blast lineage immediately descended from their pro-
genitors upon Indian hedgehog action and Runx2
expression. During vascular invasion and formation
of ossification centers, these Nes+ cells were closely
associated with each other and increased in number
progressively. Interestingly, cells targeted by tamox-
ifen-inducible cre recombinase driven by nestin
enhancer (Nes-creER) in developing bone marrow
were predominantly endothelial cells. Furthermore,
Nes+ cells in postnatal bones were heterogeneous
populations, including a range of cells in the osteo-
blast and endothelial lineage. These findings reveal
an emerging complexity of stromal populations, ac-
commodating Nes+ cells as vasculature-associated
early cells in the osteoblast and endothelial lineage.
INTRODUCTION
Bone is a multi-functional organ providing protection for vital
organs, levers for motion and withstanding gravity, and the
sole site in which hematopoietic stem cells (HSCs) normally
generate blood cells in adult mammals. Most bones are formed
through endochondral ossification, in which a cartilage template
is replaced by bone and bone marrow. During this process,
mesenchymal condensations first define the domain for the
future bones and then develop into cartilage that continues to
grow as chondrocytes proliferate (Kronenberg, 2003). When
cells in the central region stop proliferating and become hyper-
trophic, osteoblasts appear in the surrounding perichondrium
(Maes et al., 2010). A population of osteoblast precursors and330 Developmental Cell 29, 330–339, May 12, 2014 ª2014 Elsevier Inendothelial cells in the perichondrium coinvades the avascular
cartilage and establishes the primary ossification center; osteo-
blasts and stromal cells then populate the highly vascularized
bone marrow. The principal site of hematopoiesis moves from
the fetal liver to the spleen and bone marrow during late embry-
onic development (Christensen et al., 2004). Endochondral ossi-
fication establishes an HSC niche de novo within bone marrow
(Chan et al., 2009). Marrow stromal cells begin making chemo-
kines, such as chemokine (C-X-C motif) ligand 12 (CXCL12), to
support bone marrow hematopoiesis (Nagasawa et al., 1996).
A wide range of cells of endochondral bones, including endos-
teal osteoblasts (Calvi et al., 2003; Zhang et al., 2003), endothe-
lial cells, pericytes (Ding et al., 2012; Sacchetti et al., 2007), and
perivascular stromal cells, including CXCL12-abundant reticular
cells (Sugiyama et al., 2006), provides micro-environmental cues
that maintain hematopoietic stem cells in bone marrow. In adult
bone, cells expressing GFP in response to a nestin promoter/
enhancer (Nes-GFP) and those expressing Nes-creER exhibit
mesenchymal stem/progenitor activities and constitute an
essential HSC niche component (Me´ndez-Ferrer et al., 2010).
Nestin is an intermediate filament protein originally described
in neural stem cells and is also expressed in various cell types,
including pericytes and nascent endothelial cells, in the devel-
oping limb bud and growing tumors (Mokry´ et al., 2004; Teranishi
et al., 2007; Wroblewski et al., 1997). However, whether similar
nestin-expressing cells participate in the process of fetal endo-
chondral ossification and in the formation of cells that support
hematopoiesis is unknown. In this study, we sought to identify
the origin, heterogeneity, and fate of cells expressing nestin
during endochondral bone development. Our data reveal that
nestin-expressing cells are associated with vasculature and
encompass early cells in the osteoblast, stromal, and endothelial
lineages and place nestin expression downstream of Indian
hedgehog and Runx2 action in the mesenchymal lineages.
RESULTS
Development of Endothelial and Nonendothelial Nestin+
Cells during Endochondral Ossification
We studied embryonic endochondral bones using Nes-GFP
mice (Me´ndez-Ferrer et al., 2010; Mignone et al., 2004). At em-
bryonic day 10.5 (E10.5), Nes+ cells were distributed within the
limb bud, partly in a reticular pattern that resembled that ofc.
Figure 1. Development of Endothelial and Nonendothelial Nestin+ Cells during Endochondral Ossification
(A–C) E10.5 proximal limb buds of Nes-GFP mice were stained whole mount for CD31 and nuclei. In these images, green indicates EGFP signal; red represents
Alexa546 signal, and blue represents DAPI signal. (A and B) Images are340. (C) Images are3630 confocal. Scale bars represent 400 mm (A and B) and 10 mm (C).
Note that GFP is cytoplasmic and CD31 is membranous.
(D) Flow cytometry analysis of E10.5 Nes-GFP limb bud cells stained for CD45 and CD31 (n = 3). Upper panel demonstrates nucleated singlets gated for CD45;
the blue line indicates GFP control limb bud cells. Lower panel demonstrates the CD45 fraction gated for Nes-GFP+; the blue line indicates GFP+ cells in an
unstained control.
(E–I) E11.5–E15.5 femur sections ofNes-GFPmice were stained for CD31 and nuclei, and confocal images are shown at3200 (E–I). Green represents EGFP; red
represents Alexa546; and gray represents DAPI. Dorsal halves of growth cartilage are shown. Perichondrium is on top. Arrows point to CD31+Nes+ cells (E and F).
Arrowheads point to CD31Nes+ cells in the perichondrium (G and H). Asterisks in vascular invasion front indicate examples of the intimate association of
CD31+Nes+ and CD31Nes+ cells (I). Scale bars represent 50 mm.
(J) Quantification of CD31+Nes+ cells (white bars) and CD31Nes+ cells (black bars) in perichondrium and primary ossification center (n = 3–6 per group).
All data are represented as mean ± SD.
Developmental Cell
Nes+ Cells in Osteoblast and Endothelial LineagesCD31+ cells, though cells toward the distal end of the limb bud
did not show this pattern (Figures 1A and 1B). The reticular
Nes+ cells coexpressed CD31 (Figure 1C). Analysis of dissoci-Deveated limb bud cells revealed that 18.0% ± 5.4% of CD45 cells
were Nes+ and 7.7% ± 1.8% of Nes+ cells were CD31+ (Fig-
ure 1D). At E11.5, Nes+ cells were seldom found withinlopmental Cell 29, 330–339, May 12, 2014 ª2014 Elsevier Inc. 331
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Nes+ Cells in Osteoblast and Endothelial Lineagesmesenchymal condensations, and a small number of CD31+
Nes+ cells were in the area surrounding condensations (Fig-
ure 1E, arrows). When the growth cartilage appeared at E12.5,
Nes+ cells were found in the perichondrium with large numbers
expressing CD31+ (Figure 1F; Figure S1A available online,
arrows). At E13.5, a distinct group of CD31Nes+ cells appeared
in the innermost portions of the perichondrium adjacent to the
incipient hypertrophic chondrocytes and vasculature (Figure 1G
and S1B, arrowheads). At E14.5, both types of Nes+ cells domi-
nated the inner aspect of the enlarging wedge-shaped perichon-
drium, and CD31Nes+ cells were aligned on the innermost
portion of the flanking perichondrium (Figure 1H, arrowheads).
At E15.5, as vascular invasion into the cartilage template
occurred, the nascent primary ossification center was populated
by both CD31+ and CD31Nes+ cells that were closely associ-
ated with each other (Figure 1I, asterisks; see also Figure S1C).
The majority of CD31+ cells found within the perichondrium
and the primary ossification center was also Nes+. CD31+Nes
cells were foundmostly outside the bone anlage. The quantifica-
tion on confocal sections revealed that CD31+Nes+ cells
appeared earlier than CD31Nes+ cells, and both fractions
continued to increase as endochondral ossification advanced
(Figure 1J). Therefore, these data suggest that distinct endothe-
lial and nonendothelial populations of Nes+ cells are found in the
embryonic perichondrium and that these cells closely interact
with each other and increase in number during vascular invasion
and endochondral ossification.
Nonendothelial Nestin+ Cells Encompass Early Cells of
the Osteoblast Lineage
Chondrocytes and chondro-perichondrial progenitors of embry-
onic endochondral bones express type II collagen (Col2) (MaesFigure 2. Nonendothelial Nestin+ Cells Encompass Early Cells of the O
(A–C) Nes-GFP; Col2-cre; R26RTomato femur sections were stained for CD31 and
femur (right panel shows a single color view of CD31 staining). (B) Section from E1
CD31Nes+ Tomato+ cells; arrowheads point to CD31+Nes+Tomato cells.
(D) Nes-GFP; Col2-creER; R26RTomato E13.5 femur sections were stained for CD
received 2 mg tamoxifen at E12.5.
(E and F)Nes-GFP;Osx-creER;R26RTomato E13.5 femur sections were stained for
perichondrium is viewed at3200 in (E) and at3630 in (F). The lower panel in (F) sh
cells; arrowheads point to perivascular Tomato+ cells. Green indicates EGFP; red
Scale bars represent 50 mm in (A), (B), (D), and (E) and 20 mm in (C) and (F).
(G) Flow cytometry analysis of E13.5 Nes-GFP; Osx-creER; R26RTomato limb cells
fraction was gated for Tomato+; the blue line indicates the pattern of Nes-GFPT
(H) Nes-GFP; Osx-creER; R26RTomato E16.5 femur sections were viewed at 3100
point to Tomato+ cells disappearing from the osteogenic perichondrium. Green i
(I and J) Nes-GFP; Osx-creER; R26RTomato E17.5 femur sections were viewed af
nuclei and viewed at 3100. In (J) the confocal image was viewed at 3630. Arrow
perichondrium. Scale bars represent 200 mm in (H) and (I) and 50 mm in (J).
(K–M)Nes-GFP;Col2-creER; R26RTomato P0 femur sections were viewed after ad
at 3100. (L) is a confocal image of perichondrium, delineated by dotted line and
dotted line. Arrows point to CD31Nes+ Tomato+ cells. Green indicates EGFP; re
bars represent 200 mm for (K) and 20 mm for (L) and (M).
(N–P) E13.5 femur sections were stained for CD31 and nuclei. Section from a con
mouse in (P). All are confocal images at 3200. Green indicates EGFP; red indica
(Q) Quantification of CD31+Nes+ cells and CD31Nes+ cells in perichondrium. Con
per group, *p < 0.05.
(R) Quantification of CD31+Nes+ cells and CD31Nes+ cells in perichondrium. Co
n = 4 per group, *p < 0.05.
(S) Ptch1LacZ/+ femur from E13.5 mice was stained for b-galactosidase activity a
All data are represented as mean ± SD.
Deveet al., 2010; Nakamura et al., 2006; Szabova et al., 2009). To
understand how these embryonic progenitors contribute to
Nes+ populations, we tracked cell fates using triple-transgenic
mice carryingNes-GFP, constitutively activeCol2-cre (Ovchinni-
kov et al., 2000), and a Rosa26 tomato reporter (Madisen et al.,
2010). In this system, cells expressing Col2 and their descen-
dants become red, and if they express Nes-GFP concurrently,
they become yellow. At E12.5, red cells appeared mostly within
the growth cartilage and some in the perichondrium and were
completely separate from CD31+Nes+ cells (Figure 2A). At
E13.5, almost all the CD31Nes+ cells in the perichondrium
were yellow (Figures 2B and 2C, arrows), indicating that they
were either expressing Col2 or were descendants of Col2+ cells.
In contrast, CD31+Nes+ cells remained green (Figure 2C, arrow-
heads). To further test if these Nes+ cells themselves express
Col2 or descended from Col2-expressing cells, triple-transgenic
mice carrying Nes-GFP, inducible Col2-creER (Nakamura et al.,
2006), and a Rosa26 tomato reporter were generated. These
mice received tamoxifen injection at E12.5 and were observed
24 hr later at E13.5. In this paradigm, cells actively expressing
Col2 undergo recombination in the presence of tamoxifen and
become red. Col2+ cells were seen mostly within the growth
cartilage and some in the perichondrium and were completely
separate from Nes+ cells (Figure 2D). Furthermore, when mice
received tamoxifen at E13.5 and were analyzed 7 days later at
P0, descendants of Col2+ cells at E13.5 became yellow in the
perichondrium and primary spongiosa (Figures 2K–2M). There-
fore, these data suggest that the yellow cells in the perichon-
drium in Figure 2B are descended from cells, such as the red
cells in Figure 2D.
Cells expressing osterix (Osx) in the embryonic perichon-
drium are osteoblast precursors capable of differentiating intosteoblast Lineage
nuclei, and viewed with confocal microscopy at 3200. (A) Section from E12.5
3.5 femur; shown is confocal image of dotted area at3630 (C). Arrows point to
31 and nuclei, and viewed with confocal microscopy at 3200. Pregnant mice
CD31 and nuclei. Pregnant mice received 2mg tamoxifen at E12.5. Osteogenic
ows a single color view of CD31 staining. Arrows point to CD31Nes+ Tomato+
indicates tdTomato; blue indicates Alexa633; and gray staining indicates DAPI.
after administration of tamoxifen at E12.5 and staining for CD45. The CD45
omato+ limb cells (n = 3).
after administration of tamoxifen at E13.5 and stained for nuclei. Arrowheads
ndicates EGFP; red indicates tdTomato; and blue represents DAPI.
ter administration of tamoxifen at E16.5. In (I) they were stained for CD31 and
s point to CD31Nes+Tomato+ cells on the innermost layer of the osteogenic
ministration of tamoxifen at E13.5 and stained for CD31 and nuclei. (K) is shown
shown at 3630; (M) is a confocal image of primary spongiosa, delineated by
d indicates tdTomato; blue indicates Alexa633; and gray indicates DAPI. Scale
trol mouse is shown in (N), from an Ihh/ mouse in (O), and from a Runx2/
tes Alexa546; and gray indicates DAPI. Scale bars represent 50 mm.
trol cells are shown in white bars, and Ihh/ cells are shown in black bars. n = 4
ntrol cells are shown in white bars, and Runx2/ cells are shown in black bars.
nd shown at 3200. Scale bar represents 50 mm.
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Figure 3. Nes-creER Preferentially Targets Nestin+ Endothelial Cells in Developing Bone Marrow
(A) Pregnant mice received 1 mg tamoxifen at indicated points (E11.5, E13.5, or E16.5), and Nes-creER; R26RTomato mice were chased until the indicated
postnatal day (P0, P7, or P21). Distal femur sections are shown at 340. Red indicates tdTomato. Scale bars represent 500 mm.
(B)Nes-creER;R26RTomato mice received 0.1mg tamoxifen at P3 and were chased for 1month (left panels) and 6months (right panels). Upper panels show distal
femur and metaphysis at 340. Scale bars indicate 500 mm; lower panels show diaphysis at 3100. Scale bars represent 200 mm. Red indicates tdTomato.
(C) Flow cytometry analysis of epiphyseal/metaphyseal cells from Nes-creER; R26RTomato mice that received tamoxifen at P3 and were chased for indicated
periods. Cells were stained for CD45 and CD31. The upper panel shows CD45 fraction after 2 weeks of chase, gated for Tomato+. The blue line indicates the
tracing for Tomato+ cells from an unstained control. The lower panel shows the percentage of CD31+ cells within the CD45Tomato+ fraction when mice were
chased for 2 days (n = 4), 1 week (n = 6), 2 weeks (n = 2), and 4 weeks (n = 4).
(D) Nes-creER; R26RTomato were given tamoxifen at P3, and femur sections were examined. Left panels show diaphysis after 1 month of chase stained for CD31
and nuclei. Upper left is a confocal image at 3200. Arrows indicate Tomato+ osteocytes in cortical bone. Lower left is a confocal image (at 3630) of the boxed
area from the upper left, rotated perpendicularly, revealing a bone marrow sinusoid. Red indicates tdTomato; blue indicates Alexa633; and gray indicates DAPI.
Upper right panel shows a confocal image (3400) of growth plate cartilage after 2 months of chase. Note Tomato+ columnar chondrocytes. Red indicates
tdTomato, and gray indicates DAPI. Lower right panel is a confocal image at 3200, showing diaphysis after 4 months of chase, stained for lipid. Red indicates
tdTomato, and blue indicates LipidTOX Deep Red. Scale bars represent 50 mm.
(E) Flow cytometry analysis of epiphyseal/metaphyseal cells from Col1(2.3kb)-GFP; Nes-creER; R26RTomato mice. The mice received tamoxifen at P3 and were
chased for the indicated periods. Cells were stained for CD45. Upper panel shows the CD45 fraction after 2 days of chase, gated for Tomato+. The blue line
represents Tomato+ cells in an unstained control. Lower panel shows the percentage of Col1(2.3kb)-GFP+ cells within the CD45Tomato+ fraction after the mice
were chased for 2 days (n = 4), 1 week (n = 5), 2 weeks (n = 2), 3 weeks (n = 4), and 4 weeks (n = 4).
(legend continued on next page)
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Nes+ Cells in Osteoblast and Endothelial Lineagesosteoblasts, osteocytes, and peritrabecular stromal cells (Maes
et al., 2010). To understand howNes+ cells are related to osterix-
expressing precursors, triple transgenic mice carryingNes-GFP,
inducible Osx-creER, and Rosa26 tomato reporter received
tamoxifen at E12.5 and were analyzed 24 hr later at E13.5. At
E13.5, a great majority of red cells was found in the perichon-
drium (Figure 2E), and some of these cells overlapped with
CD31Nes+ cells and became yellow in the perichondrium (Fig-
ure 2F, arrows). In addition, these red cells were closely associ-
ated with, but clearly independent from, CD31+Nes+ cells
(Figure 2F, arrowheads). Analysis of dissociated limb cells
revealed that 30.7% ± 4.7% of red cells expressed Nes-GFP
(Figure 2G). Furthermore, when mice received tamoxifen at
E13.5 and were analyzed at E16.5, a large majority of descen-
dants of osterix-expressing cells at E13.5moved into the primary
ossification center and did not stay in the newly generated part of
the perichondrium (Figure 2H, arrowheads). These red cells
completely disappeared from the perichondrium when chased
until postnatal day 0 (data not shown). When mice received
tamoxifen at E16.5 and were observed 24 hr later at E17.5, the
domain of red cells extended over the Nes+ perichondrium (Fig-
ure 2I). In fact, many yellow cells were observed on the inner
aspect of the perichondrium (Figure 2J, arrows), indicating that
these CD31Nes+ perichondrial cells expressed osterix. Thus,
at least some CD31Nes+ cells in the perichondrium are Osx+
osteoblast precursors that are continually replenished from their
precursors as bones become longer.
Runx2 is an essential regulator of osteoblast differentiation
downstream of Indian hedgehog (Ihh), as Runx2 mRNA is
absent from the perichondrium in the absence of Ihh (St-Jacques
et al., 1999). The Ihh receptor, Patched1, is a direct Ihh target
gene. In Ptch1-LacZ knockin mice, robust b-galactosidase
activities were observed in the perichondrium at E11.5 (data
not shown) and E13.5 (Figure 2S), demonstrating Ihh action in
the perichondrium. To determine the role of Ihh signaling in
Nes-GFP cells, double-transgenic mice carrying Nes-GFP and
Ihh null alleles were analyzed at E13.5. The number of CD31+
Nes+ cells was significantly reduced and CD31Nes+ cells
were completely abrogated in the resultant thin perichondrium
(Figures 2O and 2Q). Runx2 deficiency also significantly reduced
the number of CD31+Nes+ cells and led to complete loss of
CD31Nes+ cells in the perichondrium at E13.5 (Figures 2P
and 2R). No CD31Nes+ cells were observed in Runx2-deficient
perichondrium when bones developed further at E16.5 and
E18.5 (data not shown). Thus, Ihh and Runx2 are required for
generating nonendothelial Nes+ cells in the perichondrium
during embryonic endochondral bone development. In addition,
Ihh and Runx2 are also important for endothelial Nes+ cells in
the perichondrium, and disappearance of CD31Nes+ cells
in Ihh null or Runx2 null embryos is likely to occur through a
combination of cell-autonomous and non-cell-autonomous
effects.
These data indicate that Ihh and Runx2 both are needed to
direct mesenchymal precursors to become Nes+ cells of the(F and G) Flow cytometry analysis of epiphyseal/metaphyseal cells from Cxcl12
chased for 1 week. (F) The CD45 fraction gated for Tomato+ (n = 6) is shown. Th
bone marrow of the femoral diaphysis were viewed with confocal images at3630
indicates tdTomato; blue staining indicates Alexa633; and gray staining indicate
Deveosteoblast lineage in the perichondrium; some of these cells
become Osx+ preosteoblasts.
Nes-creER Preferentially Targets Nestin+ Endothelial
Cells in Developing Bone Marrow
In order to unravel the fate of Nes+ cells at different stages of
endochondral ossification, we took advantage of mice express-
ing an inducible Cre recombinase under the control of a minimal
promoter and a 1.8 kb nestin second intron enhancer (Nes-
creER) (Balordi and Fishell, 2007), along with a Rosa26 tomato
reporter. Whenmice received tamoxifen before the primary ossi-
fication center was formed, either during formation of condensa-
tions at E11.5 or of the osteogenic perichondrium at E13.5, only a
small number of red cells was observed in bone upon chase until
the day of birth (P0) or until postnatal day 21 (P21). When mice
received tamoxifen at E16.5 at the time that the marrow space
starts to form, larger numbers of red cells appeared in bone,
when chased until P7 or P21 (Figure 3A). Therefore, there
appears to be a transition of Nes-creER expression before and
after the primary ossification center is established. To delineate
the fate of Nes-creER-targeted cells after bone marrow hemato-
poiesis is fully established, mice received tamoxifen at postnatal
day 3 (P3). Descendants of these cells [Nes-creER(P3)]
continued to dominate the entire bone marrow up to the border
with the growth plate, in a reticular pattern similar to marrow
vasculature for at least 6 months thereafter (Figure 3B). Analysis
of dissociated cells from the epiphysis and metaphysis revealed
that a majority of Nes-creER(P3) cells were consistently positive
for CD31 for the entire first month of chase (Figure 3C). Histolog-
ical analysis revealed that Nes-creER(P3) red cells were predom-
inantly sinusoidal endothelial cells in bonemarrow (Figure 3D, left
panels). In contrast, only a small number of Nes-creER(P3) cells
became red osteoblasts and osteocytes in the cortical bone (Fig-
ure 3D, arrows; see also Figure S2A), and very infrequently
became chondrocytes in the growth plate (Figure 3D, right upper
panel). Further, Nes-creER(P3) cells did not become adipocytes
(Figure 3D, right lower panel). To understand the contribution of
Nes-creER(P3) cells to osteoblastic cells, triple transgenic mice
carrying Col1(2.3kb)-GFP, Nes-creER, and a Rosa26 tomato re-
porter were generated and received tamoxifen at P3. Analysis of
dissociated bone cells revealed that 10.4% ± 2.3% of Nes-
creER(P3) cells were osteoblasts expressing GFP at 48 hr after
injection; this increased to 26.1% ± 5.7% and 23.2% ± 1.5%
for the first and second weeks and then decreased to 5.4% ±
0.1% and 2.9% ± 1.7% for the third and fourth weeks, respec-
tively (Figure 3E; see also Figure S2B for images).
Various types of cells in bone and bone marrow express
CXCL12, a crucial chemokine for maintaining hematopoietic
stem cells (HSCs) (Nagasawa et al., 1996), whereas depletion
of Nes-creER cells rapidly reduces HSCs (Me´ndez-Ferrer et al.,
2010). To understand how Nes-creER cells contribute to
CXCL12-expressing cells, triple-transgenic mice carrying
Cxcl12-GFP (Ara et al., 2003), Nes-creER, and a Rosa26 tomato
reporter were generated and received tamoxifen at P3. After a-GFP; Nes-creER; R26RTomato mice that received tamoxifen at P3 and were
e blue line indicates a trace of Cxcl12-GFPTomato+ cells. (G) Sections of the
after stained for CD31 and nuclei. Green staining indicates EGFP; red staining
s DAPI. Scale bars, represent 50 mm. All data are represented as mean ± SD.
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Nes+ Cells in Osteoblast and Endothelial Lineagesweek of chase, 17.8% ± 3.4% of Nes-creER(P3) cells were
Cxcl12-GFP+ (Figure 3F), and Nes-creER(P3) endothelial cells
of the arterioles were found to be Cxcl12-GFP+; some of the
Nes-creER cells were stromal cells as well (Figure 3G; see also
Figures S2C and S2D for images).
These data suggest thatNes-creER predominantlymarks cells
that become endothelial cells and cells that become osteoblasts,
osteocytes, stromal cells, and chondrocytes.
Nestin+ Cells in Developing Postnatal Bones Are
Heterogeneous Stromal Cell Populations
In postnatal endochondral bones at 1 week of age, the Nes-GFP
signal was particularly intense in two locations: perivascular cells
in the primary spongiosa immediately adjacent to the growth
plate (Figure 4A, left panel, arrows) and pericytes of the arterioles
(Figure 4A, arrowheads; see Figure 4Cbelow). In addition, amod-
erate Nes-GFP signal was found in osteoblasts on the bone sur-
face, osteocytes (Figure 4A, asterisks; see also Figure S3), and
endothelial cells (Figure 4C, asterisks). In adult endochondral
bones at 2 months of age, the number of Nes-GFPhi cells was
decreased in theprimary spongiosa andbonemarrow (Figure 4B,
left panel, arrows). Nes-GFPlo cells in osteoblasts on bone sur-
facesandosteocyteswere alsodecreasedbut still observed (Fig-
ure 4B, left panel, asterisks, right panel, arrowheads; see also
Figure S3). To delineate the difference between cell types that
Nes-GFP and Nes-creER differentially target, mice carrying
both of these transgenes were generated, received tamoxifen
at P3, and analyzed 48 hr later. A large majority of red cells tar-
geted by Nes-creER was found to be CD31+ endothelial cells in
the primary spongiosa and bone marrow (Figure 4C, asterisks).
Analysis of dissociated bone cells revealed that almost all the
Nes-creER-tomato cells were also Nes-GFP positive (Figure 4D,
left panel). However, whereas 33.7% ± 7.0% of Nes-GFP cells
were CD31+, 80.8% ± 7.2% of Nes-creER-tomato cells were
CD31+ (Figure 4D, right panels), suggesting thatNes-creER pref-
erentially targets an endothelial subpopulation of Nes+ cells. To
study if cells expressing Nes-GFP and/or Nes-creER-tomato
actually express nestin gene, we examined Nestin immunoreac-
tivity and the expression ofNestinmRNA in these cell populations
(Figures S3E–S3K). These data confirm that cells expressing
these transgenes also express nestin mRNA and protein. To
delve more into the heterogeneity of Nes+ cells in postnatal
bones, Nes-GFP was combined with cre lines targeting distinct
stromal cell lineages: Osx-cre for osteoblasts (Rodda and
McMahon, 2006), Tie2-cre for endothelial cells, and LepR-cre
for perivascular stromal cells (Ding et al., 2012). At P3 (Tie2-cre)
or P7 (Osx-cre, LepR-cre), 97.7% ± 0.7% of Osx-cre, 94.3% ±
2.9% of Tie2-cre, and 97.2% ± 0.5% of LepR-cre-targeted
CD45 cells were positive for Nes-GFP (Figure 4E). To focus
further on osteoblast subpopulations of Nes+ cells, Nes-GFP
was combined with creERT2 lines targeting different stages of
theosteoblast lineage (Osx-creER,Col1(3.2kb)-creERandosteo-
calcin (Ocn)-creER). After a pulse at P3, followed by 1 week of
chase, 95.7%± 4.8%, 91.8%± 4.5%, and 92.9%± 1.5% of cells
targeted by Osx-creER, Col1(3.2kb)-creER, and Ocn-creER,
respectively,werepositive forNes-GFP (Figure 4F). Therefore, in-
asmuch as these reporter lines are specific for their respective
lineages, Nes+ cells include a wide range of cells in the endothe-
lial, stromal, and osteoblast lineage.336 Developmental Cell 29, 330–339, May 12, 2014 ª2014 Elsevier InDISCUSSION
Establishment of hematopoiesis and bone formation within the
bone marrow during embryonic endochondral ossification
requires an orchestrated invasion of osteoblast precursors and
endothelial cells from the perichondrium into the avascular carti-
lage. Many cell types putatively supporting hematopoietic stem
cells in bone marrow, e.g., osteoblasts, stromal cells, pericytes,
and endothelial cells, are generated simultaneously as the pri-
mary ossification center forms. Our data indicate that nestin+
cells during this process are associated with vasculature and
include both endothelial and nonendothelial cells. We used
two different ‘‘nestin’’ constructs, both containing an intronic
enhancer sequence: one uses a nestin gene promoter to drive
GFP expression (Mignone et al., 2004), whereas the other uses
a minimal promoter to drive creER expression (Balordi and Fish-
ell, 2007). We found that the two constructs mark both endothe-
lial and mesenchymal cell types, with the latter marking a higher
proportion of endothelial cells in fetal and early postnatal life.
Me´ndez-Ferrer et al. (2010) showed that, in adult bone
marrow, Nes-GFP+ cells include all cells capable of forming
CFU-F colonies in vitro; these colonies form from single cells
and can generate osteoblasts, chondrocytes, and adipocytes
in vitro. Also, they showed thatNes-creER-targeted cells in adult
marrow could become osteoblasts, osteocytes, and chondro-
cytes in vivo and were also required to support hematopoiesis.
We used a series of cell-type-specific transgenes and mutant
mice to order the expression of the nestin transgenes in fetal
bone. We found that neither of these transgenes was expressed
in mesenchymal condensations. Nes-GFP was expressed in
endothelial and nonendothelial cells in the perichondrium. The
latter cells appeared downstream of cells expressing transgenes
driven by the type II collagen promoter: Col2-cre-tomato
reporter marked chondrocytes and perichondrial cells distinct
from cells expressing Nes-GFP+ at E12.5. Similarly, when
Col2-creER mice were given tamoxifen at E12.5 and examined
at E13.5, the marked cells were distinct from cells expressing
Nes-GFP. When similar mice given tamoxifen at E13.5 were
examined at P0, many Nes-GFP+ cells were descended from
those expressing Col2-creER at E13.5. These findings allow
us to place Nes-GFP expression downstream of Col2-creER
expression in the lineage of fetal perichondrial cells.
It is of interest that, in fetal life, neither nestin construct marks
the mesenchymal condensations that give rise to chondro-
cytes and osteoblasts; they appear in the perichondrium only
after Col2+ cells populate there. Thus, multi-lineage potential
is not solely a property of the earliest cells of the osteoblast
lineage during development. Further, because osteoblasts
and bone lining cells are also Nes+ (Figures 4A and 4B; Fig-
ure S3), it is unlikely that all Nes+ cells are multipotent in normal
development.
Mice with the Ihh gene ablated fail to form osteoblasts in limb
perichondrium (St-Jacques et al., 1999). We found that these
mice also fail to generate perichondrial cells expressing Nes-
GFP. Mice with the Runx2 gene ablated fail to form osteoblasts
(Otto et al., 1997), and these mice fail to generate perichondrial
cells expressing Nes-GFP. Thus, perichondrial CD31Nes-
GFP+ cells require both Ihh and Runx2 expression and also
appear after expression of the Col2-cre transgene. In contrast,c.
Figure 4. Nestin+ Cells in Developing Postnatal Bones Are Heterogeneous Stromal Cell Populations
(A and B) Distal femur sections ofNes-GFPmice at (A) 1 week of age and (B) 2months of age were stained for nuclei. Confocal images at3100 of metaphysis (left
panels) and diaphysis (right panels) are shown. Arrows indicate Nes-GFPhi cells in the primary spongiosa adjacent to the growth plate. Arrowheads in (A) point to
pericytes of bone marrow arterioles; asterisks indicate osteoblasts on the bone surface and osteocytes. Arrowheads in (B) point to osteocytes in cortical bone.
Scale bars represent 100 mm.
(C and D)Nes-GFP;Nes-creER;R26RTomato mice received tamoxifen at P3 and were chased for 48 hr. (C) Femur sections of metaphysis (left panel) and diaphysis
bone marrow (right panel) were stained for CD31 and nuclei and viewed with confocal microscopy at3630. Asterisks indicate CD31+Tomato+ cells. Arrows point
to pericytes of bone marrow arterioles. Green indicates EGFP; red represents tdTomato; blue represents Alexa633; and gray represents DAPI. Scale bars
represent 20 mm. (D) Flow cytometry analysis of epiphyseal/metaphyseal cells stained for CD45 andCD31. CD45 fraction gated for Tomato+ (left panel and lower
right panel) and Nes-GFP+ (upper right panel) (n = 4); blue line: Nes-GFPTomato+ cells (left panel) and unstained controls (right panels).
(E) Flow cytometry analysis of epiphyseal/metaphyseal cells fromNes-GFP;R26RTomato mice that also carryOsx-cre (left panel), Tie2-cre (center panel), or LepR-
cre (right panel). Cells were harvested at P3 (Tie2-cre) or P7 (Osx-cre, LepR-cre).
(F) Flow cytometry analysis of epiphyseal/metaphyseal cells from Nes-GFP; R26RTomato mice that also carryOsx-creER (left panel), Col1-creER (center panel), or
Ocn-creER (right panel). Tamoxifen was administered at P3 and cells were harvested a week later. The CD45 fraction was gated for Tomato+. ForOsx-cre cells,
n = 3; for Tie2-cre cells, n = 4; for LepR-cre cells, n = 3, for Osx-creER cells, n = 6; for Col1-creER cells, n = 4; and for Ocn-creER cells, n = 3. The blue lines
represent a GFP control. All data are represented as mean ± SD.
Developmental Cell
Nes+ Cells in Osteoblast and Endothelial Lineageswhen Osx-creER is activated at E12.5, many CD31Nes-GFP+
cells at E13.5 expressed the tomato reporter. Similarly, when
Osx-creER is activated at later times, expression of the tomato
reporter largely overlaps with expression of Nes-GFP. Also,Deveboth Col1-creER and Ocn-creER marked a subset of Nes-
GFP+ cells. Thus, the CD31Nes-GFP+ cells appear roughly at
the time of Osx expression, and Nes-GFP transgene remains
active in subsequent cells of the osteoblast lineage.lopmental Cell 29, 330–339, May 12, 2014 ª2014 Elsevier Inc. 337
Developmental Cell
Nes+ Cells in Osteoblast and Endothelial LineagesNes-creER directs reporter expression in nonendothelial
stromal cells in the marrow, and LepR-cre also directs expres-
sion in Nes-GFP+ cells; thus, stromal cells represent one fate
for nestin-expressing cells. In the accompanying manuscript,
Mizoguchi et al. (2014; this issue of Developmental Cell) show
that postnatally marked cells expressing Nes-GFP and Osx-
creER-tomato include stromal cells with properties of ‘‘mesen-
chymal stem/progenitor cells.’’
Endosteal osteoblasts, endothelial cells, pericytes, and
perivascular stromal cells have been implicated in defining the
hematopoietic stem cell niche in bone marrow (Ding et al.,
2012; Ding and Morrison, 2013; Greenbaum et al., 2013). Our
data indicate that all these cell types in developing bone marrow
express Nes-GFP. We also found that Nes-creER predominantly
targets endothelial cells in bone marrow, including Cxcl12+
endothelial cells of the bone marrow arteriole (Figure 3G). Our
findings support the notion that both endothelial and nonendo-




Nestin-GFP, Col2a1-cre, Osx-cre, Col2a1-creERT2, Osx-creERT2, Col1-
creERT2, Ocn-creERT2, Ihh-Neo/null, Runx2-LacZ/null, Ptch1-LacZ/null, and
Cxcl12-GFP/null mice have been described elsewhere. Tie2-cre (JAX8863),
LepR-cre (JAX8320), and Rosa26-loxP-stop-loxP-tdTomato (R26R-tomato,
JAX7914) were acquired from Jackson Laboratory. All procedures were con-
ducted in compliance with the Guideline for the Care and Use of Laboratory
Animals approved by Massachusetts General Hospital’s Institutional Animal
Care and Use Committee (IACUC). For embryonic experiments, male mutant
mice were mated to female CD1 mice, and the vaginal plug was checked in
the morning. Pregnant mice received 1 mg tamoxifen (Sigma T5648) and
progesterone (Sigma P3972) intraperitoneally (i.p.). For postnatal experiments,
3-day-old mice received 0.1 mg of tamoxifen i.p. Tamoxifen was dissolved
first in 100% ethanol and then in sunflower seed oil (Sigma S5007) overnight
at 60C.
Histology and Flow Cytometry
Frozen sections at 15 mm thickness were analyzed using a fluorescence (Nikon
Eclipse E800) or a confocal (Zeiss LSM510) microscope. Enzymatically
digested cells from dissected femurs and tibias were stained for anti-mouse
CD45-APC, CD31-eFlour 450 (1:500, eBioscicence) and analyzed using a
four-laser BD LSRII flow cytometer. More detailed experimental procedures
are available in the Supplemental Experimental Procedures.
Statistical Analysis
Results were represented as mean values ± SD. Statistical evaluation was
conducted based on Mann-Whitney’s U-test. A p value of <0.05 was consid-
ered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2014.03.014.
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